Search

everythinglearnresearchcommunity

for

Search:↓

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Certain metabolites can either protect against or increase the risk of hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.